Influence
August 25, 2020

Regenstrief CEO provides feedback to NLM on needs of health services researchers

Peter Embí, M.D., M.S., president and chief executive officer of Regenstrief Institute, was one of three people on a National Library of Medicine (NLM) panel to discuss the current and future needs of health services researchers.

Since the early 1990s and the establishment of the  National Information Center on Health Services Research and Health Care Technology (NICHSR), NLM has taken steps to ensure that its general activities and its core collections of journals, books and manuscripts reflect the current state of health services research. Additionally, NLM has developed specialized tools, resources and activities targeted toward the health services research community to address challenges in accessing certain information understood to be needed by the researchers.

During the webinar, Dr. Embí discussed how he and his colleagues at Regenstrief and Indiana University School of Medicine use the current tools and resources, which are the most critical and which research and policy areas need NLM focus and support.

Dr. Embí was joined on the panel by Anthony K. Wutoh, PhD, provost and chief academic officer at Howard University and Nate C. Apathy, PhD, a former pre-doctoral fellow at Regenstrief and Indiana University Richard M. Fairbanks School of Public Health at IUPUI and currently a postdoctoral fellow at the University of Pennsylvania.

Related News

Rachel Patzer, PhD

Factors Affecting Treatment Selection Among Patients With Hidradenitis Suppurativa

Published in JAMA Dermatology. Here is a link to the article.   Regenstrief Institute authors:  Rachel Patzer, PhD, MPH

Thomas Imperiale

Next generation stool DNA test has best detection rate of noninvasive colorectal cancer screening tools

Study of highly sensitive noninvasive test published in New England Journal of Medicine A study of more than 21,000

Rachel Patzer, PhD, MPH and Kalli Koukounas, MPH

JAMA study finds facilities treating poor patients penalized by CMS payment model

Social risk and treatment for end-stage kidney disease A new study of more than 2,000 dialysis facilities randomized to